Abstract | OBJECTIVE: METHODS: RESULTS: Serum GPDA was separated into two bands, namely fast band (GPDA-F) and slow band (GPDA-S). GPDA-F was negative in all healthy persons as well as in the patients with benign liver filling defects, while it was positive in 85.3% cases of PHC. Liver cirrhosis, chronic hepatitis, extrahepatic carcinoma and metastatic liver carcinoma had low positive rates. GPDA-F was positively correlated with serum total GPDA activities, but had no correlation with AFP and size of the tumors. There was the correlation between GPDA-F and ALT in benign liver diseases, but no correlation between GPDA-F and ALT in PHC. Serial measurements of serum GPDA-F showed that GPDA-F was persistently positive in PHC but might change into negative in benign liver diseases. Dynamic determination of GPDA-F might be helpful to differentiate true positive of PHC from false positive of benign liver diseases. CONCLUSION: GPDA-F is a new serum marker of PHC. Measurement of serum GPDA-F is of value for the diagnosis of PHC, especially for those at early stage or with negative AFP.
|
Authors | M Li, R Ni, J Huang, M Xiao, H Zhang, Q Wei, F Jiang, X Meng |
Journal | Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
(Zhonghua Gan Zang Bing Za Zhi)
Vol. 8
Issue 3
Pg. 139-41
(Jun 2000)
ISSN: 1007-3418 [Print] China |
PMID | 10880158
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Isoenzymes
- Alanine Transaminase
- Aminopeptidases
- glycylproline dipeptidyl aminopeptidase
|
Topics |
- Alanine Transaminase
(blood)
- Aminopeptidases
(blood)
- Carcinoma, Hepatocellular
(diagnosis, enzymology)
- Humans
- Isoenzymes
(blood)
- Liver Neoplasms
(diagnosis, enzymology)
|